Alexandre Jagerschmidt

Sanofi R&D
Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma.

Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma.

Journal: Allergy

Published: November 13, 2025

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.

Journal: Allergy

Published: December 05, 2023

Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab.

Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab.

Journal: The Journal of allergy and clinical immunology

Published: June 23, 2023

Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.

Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.

Journal: The Annals of otology, rhinology, and laryngology

Published: June 16, 2023

Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy.

Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy.

Journal: Clinical transplantation

Published: September 30, 2020

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: April 23, 2020

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 03, 2019

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.

Journal: British journal of pharmacology

Published: February 27, 2019

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.

Journal: The journal of allergy and clinical immunology. In practice

Published: January 31, 2019

Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.

Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.

Journal: Chest

Published: May 09, 2018

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 06, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026